1D·

United Health a great opportunity ?

$UNH (-1.67%)

attachment




$UNH (-1.67%) is a full-stack company in the healthcare sector.


It has two main business units: UnitedHealthcare and Optum.


UnitedHealthcare provides health insurance, while Optum provides care services and pharmacy benefits management.

attachment

Customers pay premiums to UnitedHealthcare.


When they need care, they primarily use Optum and $UNH (-1.67%) pay Optum for their care.

attachment

Optum not only provides the company with operational benefits, but also generates significant external revenue.


Many other insurers and employers also use Optum's care network and benefits administration for pharmacies.


This generates considerable external revenue.

attachment

This model has worked incredibly well for $UNH (-1.67%) worked incredibly well so far.


Although the company is the largest health insurer in the world, it has been able to increase its turnover by 11% annually over the last five years.


In the last quarter, the company gained a record 700,000 customers, an amazing achievement.

attachment

UnitedHealth Group (UNH) Annual % Change

attachment

2025 - 39.62%

2024 - 2.41%

2023 0.79%

2022 6.94%

2021 45.2%

2020 21.25%

2019 20%

2018 14.52%

2017 39.83%

2016 38.41%

2015 18.27%

2014 36.46%

2013 41.04%

2012 8.6%

2011 42.18%

2010 19.91%

2009 14.75%

2008 -54.26%

2007 8.38%

2006 -13.49%

2005 41.22%

2004 51.38%

2003 39.4%

2002 18.04%

2001 15.37%

2000 131.18%

1999 23.44%

1998 13.29%

1997 10.49%

1996 31.13%

1995 44.97%

1994 19.02%

1993 33.49%

1992 52.75%

1991 220.6%

1990 92.15%

1989 169.46%

1988 24.1%

1987 56.71%

1986 18.29%

1985 164.44%

attachment

Also a positive sign:


United Healthcare $UNH (-1.67%) has recently seen considerable insider buying.


On May 16, CEO Hemsley bought 86,700 shares for 25 million dollars.


He was previously CEO of United Healthcare from 2006 to 2017 $UNH (-1.67%) and took office again in May. He now owns 1,112,339 shares worth around 340 million dollars


John Rex, President and CFO of the company, also bought 5 million dollars worth of shares on May 16 to increase his stake, which is now worth around 60 million dollars.


$CNC (-0.38%)
$OSCR
$CVS (+0.48%)
$CI (+0.89%)

24
36 Comments

JPMorgan upgrades rating to 'overweight'. New price target $418.00 after previously $405.00.
3
profile image
As always, very interesting, even if I don't see them as an investment case in the next few years.
I have a small comment: could it be that you have forgotten the minus signs in the list of annual returns for 2024 and 2025?
For me, these figures in particular show that things have been going downhill in this area since 2022.
1
profile image
@Multibagger thank you 😂 , correction, I did indeed. But you also have to consider that the last 2 years have been very much driven by negative news, a death and a number of accusations that I think are commonplace in the business practice of the entire industry. (As in so many other sectors, but with health as a topic, it is more emotional) The Trump administration with cost reductions in the healthcare system, pharmacy business etc. is also putting pressure on the entire healthcare sector, where it is slowly becoming apparent that reductions cannot be implemented so easily and there is political resistance.

One of the most important points is that the old CEO who made $UNH big and led it for years has taken the helm again. He has also made individual business areas big and knows how things work in the company and has access to the documents. If things were as dramatic as the media report, he would probably not have taken over the helm again for liability reasons, because otherwise he might have knowingly committed or accepted a breach of duty.

So I see this as an opportunity from a short-term, medium-term and long-term perspective.

Always from the point of view that you will outperform an MSCI World over 3-5 years, which I assume of all the stocks in my portfolio.

How long I will hold this position is not yet certain, but I could well imagine it as a stable anchor, if you want to get in here then now, when so much negative is priced in, many are always waiting for such opportunities, but then do not have the courage to go through with it.

Can we fall another 10-20%? Sure
But I see an extremely attractive risk/reward ratio here.

Any comments, or even penalties, would probably even boost the share price if the issues that have largely been spread by the media in the past are confirmed or refuted.

Calm is slowly returning, the price is just waiting to break out and I also believe that the healthcare sector and value has some catching up to do and will do better if there is unrest on the stock market. I see similar opportunities at $MC, especially if the dollar continues to fall and interest rates in Europe also continue to fall, as the dividend and dividend growth are also becoming increasingly attractive, regardless of the withholding tax and transaction tax in France.

I currently feel very comfortable with my portfolio, especially as all existing and not newly acquired companies / shares have performed extremely strongly and I expect this to continue.

I think the right growth companies in the right sectors in the US will largely perform better than MAG7 over the next 5 years, and by that I don't mean $PLTR or other companies that are already astronomically valued.

In fact, I consider my companies with my investment case to be undervalued and slowly but steadily (without hype) many others are realizing this too.

It remains exciting, I'm waiting for setbacks in the market to stock up or collect more, especially on companies like $LMND that are not yet profitable.

About 30% short ratio

Collecting companies in the growth phase 1-2 years before profitability (if they make it) and finding them is one of the most exciting tasks, where I am usually a little too early, but has worked well so far.


Finding an understanding of companies that are wrongly received by the market is extremely exciting. ✌️
2
profile image
@BamBamInvest I agree with you on some points. It's just that our expectations for equity investments in terms of returns are different. You want to outperform the MSCI World. I want a potential increase of at least 25-30%. Therefore rather growth. And I see that with some of your investments. Not with $UNH. But you don't have to justify yourself for that. I am very happy to exchange ideas with you.
1
profile image
@Multibagger Normally I have the same return expectations as you, but I would like to take some volatility out of it, my portfolio has now made over 50% in 2 months and I assume that it could become a bit more volatile in the next 3 months and $UNH could quickly make 25-30% with a positive outlook and benefit from the volatility. I can well imagine switching to other companies, but one or two companies would have to correct a little 😁.
1
profile image
@BamBamInvest I just take the profits in between, like with $HIMS, which I also discovered through you. I got in at €30 and out at €52. That was 70% in just a few weeks. I assume that this will not continue. Same with $HOOD. I also sold them at just under 80%. I am convinced of both in the long term. However, as my overriding goal is still to get from €3,000 to €100,000 in 10 years, I can't afford to sit out months of sideways phases in individual stocks. My portfolio volume is still too low for that. The capital has to earn money. In the 27 months since I started in April 23, I have so far made 400% from 3,000 to 15,000. Of course, that's much more than I need for my goal and I'm sure it won't go on like this. I just need as much volatility as possible and that hasn't been there for the last few weeks. So this month will be rather modest by my standards in terms of performance, unless something extraordinary happens in the last week. I would buy $UNH if it goes down to $280 or rises above $325. And then leveraged long. In between, it is uninteresting for me.
1
profile image
@Multibagger the vola will come in the next 3 months 👍
1
profile image
1
profile image
@Multibagger things are just going too well for me, economically and geopolitically the market is somehow too resistant, I don't really trust the market, which was also the reason why I built up some cash.
1
profile image
@BamBamInvest I also think that there will be movement in the next 6-8 weeks. The Middle East conflict, the tariff breaks with the EU are coming to an end. The China cow is not off the ice either. A correction of 5-10% would be good. America may slide into stagflation by the end of the year. All top conditions for higher volatility and good entry prices for our stocks under review.
1
profile image
@Multibagger what else do you have on your prioritized watchlist besides $LMND? Any stocks where you would like to buy the setback? You should take a look at $IREN, which is also a potential 10x investment for me, not because of the miner activity but because of the AI data center.
1
profile image
@Multibagger $IREN is probably one of the best hyper-growth stocks currently on the market.

Exceptionally well positioned data center developer with a huge portfolio of grid-connected properties and power - something very valuable given the current power supply crisis in the US.

They also run an extremely tight operation - while none of the public $BTC miners are currently operationally profitable, $IREN stands out as the ONLY company that has been able to profitably mine $BTC in the last 6 months while generating approximately 16% net after tax margins.

They are now applying their expertise in AI/HPC and transforming their land and power portfolio into massive AI data center hubs.

Could be really exciting 🚀
1
View all 23 further answers
Connect with https://t.me/coachty_23 if you’re looking to invest in crypto
Join the conversation